Imene Zerizer on Muck Rack

Imene Zerizer

As seen in: The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Imene

Contact Imene, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial

|
By Mary Gleeson, Andrew Wotherspoon, Ayoma D Attygalle, Ian Chau, Peter Johnson, Kirit Ardeshna, Eliza A Hawkes, Clare Peckitt, Laurice Edwards, Jacqueline Oates, Imene Zerizer, Bhupinder Sharma, Sue Chua, Ruwaida Begum, Marian P Macheta
| The Lancet Verified
The number of complete responses or unconfirmed complete responses in the GEM-P group was non-significantly inferior to the CHOP group, indicating that the primary endpoint of the trial would not be met. A planned subgroup analysis showed that the effect was consistent across subgroups.As part of a preplanned analysis, we also assessed the proportion of agreement between contrast-enhanced CT and 18F-FDG-PET-CT for determining a complete response, and found it to be around 77%.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified